Session IX: Hematopoietic stem cell transplantation in solid tumors (1)

@article{Freund1999SessionIH,
  title={Session IX: Hematopoietic stem cell transplantation in solid tumors (1)},
  author={Mathias Freund and Kurt Possinger},
  journal={Bone Marrow Transplantation},
  year={1999},
  volume={23},
  pages={S17-S18}
}
High dose therapy with autologous blood stem cells support is a promising treatment for patients with high risk breast cancer, stage 2 (with more than 9 involved lymph nodes), imflammatory breast cancer and possibly for metastatic breast cancer too. Preliminary data obtained in uncontrolled studies are positive and show a 60 to 70% disease-free-survival in the adjuvant setting for patients with stage 2 more than 9 lymph nodes involved breast cancer at 5 years. Confirmatory randomized studies… CONTINUE READING